Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R43/R44)

Funding Opportunity RFA-HL-15-030 from the NIH Guide for Grants and Contracts. The primary objective of this funding opportunity announcement is to support the development of improved techniques and tools to enhance the production of clinically-relevant, functional stem cell-derived red blood cells or platelets in a more efficient and cost-effective manner. The research supported will develop and enhance technologies that enable the production of functional stem cell-based therapies with potential commercial and clinical viability.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding